The global vaccine contract manufacturing market by revenue is expected to grow at a CAGR of approx. 13% during the period 2020–2026
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Vaccine Contract Manufacturing Market Report. The global vaccine contract manufacturing market by revenue is expected to grow at a CAGR of approx.
April 16, 2021 09:32 ET
| Source:
ReportLinker
ReportLinker
Lyon, FRANCE
New York, April 16, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Vaccine Contract Manufacturing Market - Global Outlook and Forecast 2021-2026" - https://www.reportlinker.com/p06063357/?utm_source=GNW
13% during the period 2020–2026.
The global vaccine contract manufacturing market has experienced radical transformations after the outbreak of the COVID-19 pandemic, which has been a massive health catastrophe. Vaccine CMOs have gained significant attention as the virus starts spreading far and wide. A new era of vaccine and biological drug development has prevailed since the advent of the COVID-19 virus. The global pandemic has fueled vaccine innovations with the rapid acceleration of RNA-based COVID vaccines. Contract manufacturing companies are working to increase the availability of COVID-19 vaccines across the globe.